secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeward Ltd. (LFWD)
CIK:        0001607962
Form:       8-K
Filed at:   2024-08-15T23:59:59+00:00
Accession:  0001178913-24-002647
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifeward Q2 2024 revenue $6.7M (+400% YoY); net loss $0.50/shr, guidance reaffirmed
--------------------------------------------------------------------------------

- Revenue of $6.7M, up from $1.3M in Q2 2023; ReWalk historical product revenue rose 131%.
- Net loss of $4.3M ($0.50/shr) vs. $4.6M ($0.55/shr) a year ago; adjusted net loss $3.6M ($0.42/shr).
- Record 20 ReWalk systems placed; Medicare claims from prior quarters beginning to be paid.
- Cash $15.1M with no debt; FY 2024 revenue guidance maintained at $28M-$32M.
- Launched NEO anti-gravity treadmill; FDA submission for 7th-gen ReWalk completed in June.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1607962/000117891324002647/0001178913-24-002647-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1607962/000117891324002647/zk2431866.htm
  HTML page:      https://secwatch.observer/filing/0001178913-24-002647

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer